Connor, Clark & Lunn Investment Management Ltd. 4 D Molecular Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $21.8 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
SELL
$15.16 - $23.26 $408,941 - $627,438
-26,975 Reduced 55.28%
21,824 $394,000
Q1 2023

May 09, 2023
BUY
$15.45 - $23.19 $9,285 - $13,937
601 Added 1.25%
48,799 $838,000
Q4 2022

Feb 10, 2023
BUY
$6.85 - $25.46 $330,156 - $1.23 Million
48,198 New
48,198 $1.07 Million

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $666M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email